Biosynthema Overview

  • Founded
  • 2001

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Biosynthema General Information


Provider of drug development and discovery services. The company develops and researches on radiopharmaceuticals for diagnostic and therapeutic applications.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108
  • United States
+1 (314) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosynthema Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biosynthema‘s full profile, request access.

Request a free trial

Biosynthema Executive Team (1)

Name Title Board Seat Contact Info
Jack Erion Ph.D President and Chief Executive Officer
To view Biosynthema’s complete executive team members history, request access »